 |
PDBsum entry 1c9r
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/immune system/DNA
|
PDB id
|
|
|
|
1c9r
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
558 a.a.
|
 |
|
|
|
|
|
|
|
430 a.a.
|
 |
|
|
|
|
|
|
|
214 a.a.
|
 |
|
|
|
|
|
|
|
220 a.a.
|
 |
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Lamivudine (3tc) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-Branched amino acids.
|
 |
|
Authors
|
 |
S.G.Sarafianos,
K.Das,
A.D.Clark,
J.Ding,
P.L.Boyer,
S.H.Hughes,
E.Arnold.
|
 |
|
Ref.
|
 |
Proc Natl Acad Sci U S A, 1999,
96,
10027-10032.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
An important component of triple-drug anti-AIDS therapy is 2',
3'-dideoxy-3'-thiacytidine (3TC, lamivudine). Single mutations at residue 184 of
the reverse transcriptase (RT) in HIV cause high-level resistance to 3TC and
contribute to the failure of anti-AIDS combination therapy. We have determined
crystal structures of the 3TC-resistant mutant HIV-1 RT (M184I) in both the
presence and absence of a DNA/DNA template-primer. In the absence of a DNA
substrate, the wild-type and mutant structures are very similar. However,
comparison of crystal structures of M184I mutant and wild-type HIV-1 RT with and
without DNA reveals repositioning of the template-primer in the M184I/DNA binary
complex and other smaller changes in residues in the dNTP-binding site. On the
basis of these structural results, we developed a model that explains the
ability of the 3TC-resistant mutant M184I to incorporate dNTPs but not the
nucleotide analog 3TCTP. In this model, steric hindrance is expected for NRTIs
with beta- or L- ring configurations, as with the enantiomer of 3TC that is used
in therapy. Steric conflict between the oxathiolane ring of 3TCTP and the side
chain of beta-branched amino acids (Val, Ile, Thr) at position 184 perturbs
inhibitor binding, leading to a reduction in incorporation of the analog. The
model can also explain the 3TC resistance of analogous hepatitis B polymerase
mutants. Repositioning of the template-primer as observed in the binary complex
(M184I/DNA) may also occur in the catalytic ternary complex (M184I/DNA/3TCTP)
and contribute to 3TC resistance by interfering with the formation of a
catalytically competent closed complex.
|
 |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Superposition of the polymerase active sites of
wild-type HIV-1 RT/DNA/Fab and M184I HIV-1 RT/DNA/Fab. The
wild-type RT complex is shown in white, the mutant RT complex in
cyan. The wild-type and M184I RT structures were superimposed on
the basis of the core of the p66 palm subdomains (residues 107
to 112 and 151 to 215 of their corresponding p66 subunits).
|
 |
Figure 3.
Fig. 3. Ribbon diagram of the superimposed polymerase
active sites of wild-type HIV-1 RT/DNA/Fab and M184I HIV-1
RT/DNA/Fab. The wild-type protein and DNA are shown in gray, the
mutant protein in red, and DNA in the mutant RT/DNA complex in
yellow.
|
 |
|
 |
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Structure and functional implications of the polymerase active site region in a complex of HIV-1 rt with a double-Stranded DNA template-Primer and an antibody FAB fragment at 2.8 a resolution.
|
 |
|
Authors
|
 |
J.Ding,
K.Das,
Y.Hsiou,
S.G.Sarafianos,
A.D.Clark,
A.Jacobo-Molina,
C.Tantillo,
S.H.Hughes,
E.Arnold.
|
 |
|
Ref.
|
 |
J Mol Biol, 1998,
284,
1095-1111.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Ribbon [Carson 1987] diagram showing the overall
structure of the HIV-1 RT/dsDNA/Fab28 complex. The subdomains of
the p66 and p51 subunits of HIV-1 RT are colored as follows:
fingers, blue; palm, red; thumb, green; connection, yellow; and
RNase H, orange. The bound dsDNA is shown with the template
strand as a dark gray ribbon and the primer strand as a light
gray ribbon; base-pairs are represented by bars. The monoclonal
antibody fragment Fab28 is shown with the light chain in light
gray and the heavy chain in dark gray.
|
 |
Figure 3.
Figure 3. (a) Structure of the polymerase active site region
of HIV-1 RT including the primer grip. Secondary structural
elements of the p66 palm subdomain are shown as red ribbons. The
three catalytically essential aspartic acid residues (Asp110,
Asp185, and Asp186) are shown with cyan side-chains. Tyr183 and
Met184, which form part of the conserved YMDD motif, are shown
with gold side-chains. Amino acid residues at the primer grip
are shown in green. The dsDNA is shown with the template strand
in dark gray and the primer strand in light gray. (b) A
schematic diagram showing interactions between the 3′-terminal
nucleotide of the primer strand (Pri1) and amino acid residues
at the polymerase active site, with selected distances given in
Å. Hydrogen-bonding interactions between the side-chain
O^δ1 atom of Asp185 and the 3′-OH of Pri1, and between the
amide nitrogen atom of Met230 of the primer grip and the
phosphate oxygen atom of Pri1 are indicated by heavy lines.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from Elsevier
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Touching the heart of HIV-1 drug resistance: the fingers close down on the dntp at the polymerase active site.
|
 |
|
Authors
|
 |
S.G.Sarafianos,
K.Das,
J.Ding,
P.L.Boyer,
S.H.Hughes,
E.Arnold.
|
 |
|
Ref.
|
 |
Chem Biol, 1999,
6,
R137.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |